Cardiovascular Autonomic Responses to Aerobic, Resistance and Combined Exercises in Resistance Hypertensive Patients

Table 1

General characteristics of resistant hypertensive subjects (RH) and nonresistant hypertensive subjects (NON-RH).

	RH ()	NON-RH ()	value
Clinical data
Age (years)			0.66
Female gender, (%)	6 (60)	5 (50)	1
Diabetes mellitus, (%)	10 (100)	5 (50)	0.03
BMI (kg/m^2)			0.18
Free-fat mass (kg)			0.40
Fat mass (kg)			0.32
Total body water (L)			0.17
Basal metabolic rate (cals/day)			0.39
Office SBP (mmHg)			0.02
Office DBP (mmHg)			0.08
Office MBP (mmHg)			0.12
Office HR (bpm)			0.03
Biochemical data
HbA1C (%)		6 ± 0.7	0.13
Glucose (mg/mL)			0.07
Creatinine (mg/mL)			0.81
Aldosterone (pg/mL)			0.64
Creat Clear (mL/min/1.73m^2)			0.86
Cholesterol (mg/mL)			0.55
HDL-c (mg/mL)			0.07
LDL-c (mg/mL)			0.88
Triglycerides (mg/mL)			0.97
Anti-HT drugs
Number of classes			0.13
Diuretics, (%)	10 (100)	5 (50)	0.03
Spironolactone, (%)	2 (20)	2 (20)	1
Beta-blockers, (%)	8 (80)	6 (60)	0.63
ACEIs and ARBs, (%)	5 (50)	7 (70)	0.65
CCBs, (%)	8 (80)	3 (30)	0.07
Others, (%)	0	0	1

According to data distribution, values are expressed as mean ± standard deviation or median (1st, 3rd quartiles). RH: resistant hypertensive subjects; NON-RH: nonresistant hypertensive subjects; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; HR: heart rate; HbA1C: glycated hemoglobin; Creat Clear: creatinine clearance; LDL and HDL: low- and high-density lipoproteins, respectively; antiHT: antihypertensive drugs; ACEIs: angiotensin-converting enzyme inhibitors; ARBS: angiotensin receptor blockers; CCBs: calcium channel blockers.